Helix Therapeutics' Series A Round

Helix Therapeutics raised a round of funding on November 24, 2010.

Helix is pursuing therapies for HIV/AIDS and genetic diseases, such as sickle cell anemia and b-Thalassemia, two of the most common human genetic diseases. The company's technology, developed at the …

Articles about Helix Therapeutics' Series A Round: